Home › Bladder Cancer › Florida › Gainesville
Bladder Cancer clinical trials in Gainesville, FL
4 studies for Bladder Cancer are looking for participants at sites in and around Gainesville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Testing the Addition of the Immunotherapy Drug, Pembrolizumab, to Radiation Therapy Compared to the Usual Chemotherapy Treatment During Radiation Therapy for Bladder Cancer, PARRC Trial
RecruitingPhase 2
- UF Health Cancer Institute - Gainesville, Gainesville
Phase 2 Study to Evaluate Safety and Efficacy of Cretostimogene Grenadenorepvec in High-Risk NMIBC
RecruitingPhase 2
- University of Florida, Gainesville
Testing the Addition of an Anti-Cancer Drug, Gemcitabine, to Usual Treatment (BCG Alone) in People Whose Non-Muscle Invasive Bladder Cancer (NMIBC) Came Back After Prior BCG Therapy
RecruitingPhase 3
- UF Health Cancer Institute - Gainesville, Gainesville
Intravesical Gemcitabine and Docetaxel for Low Grade Intermediate Risk Bladder Cancer
RecruitingPhase 2
- University of Florida, Gainesville
About Bladder Cancer
Bladder cancer symptoms range from lower back pain to blood in your urine. Read about important risk factors and find a list of treatments available
More about Bladder Cancer on MedlinePlus
Bladder Cancer trials in other cities
- New York City, NY34 studies
- Houston, TX31 studies
- Nashville, TN31 studies
- Boston, MA27 studies
- Dallas, TX27 studies
- Washington, DC26 studies
- Los Angeles, CA24 studies
- Baltimore, MD24 studies
- St. Louis, MO22 studies
- Edison, NJ22 studies
- Philadelphia, PA21 studies
- Seattle, WA21 studies
Other studies in Gainesville
- Parkinson's Disease13 studies
- Heart Failure13 studies
- Breast Cancer12 studies
- Type 1 Diabetes12 studies
- Non-Small Cell Lung Cancer10 studies
- Colorectal Cancer9 studies
- Lung Cancer9 studies
- Cardiovascular Disease9 studies
- Cancer (all types)9 studies
- Prostate Cancer8 studies
- Acute Myeloid Leukemia8 studies
- Mild Cognitive Impairment8 studies
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.